Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




Charles Schwab Misses by a Penny – Analyst Blog

Zacks Market Commentaries (October 16th, 2009) Writes:
Charles Schwab Corporation’s (SCHW) third quarter earnings of 17 cents per share were only a penny short of the Zacks Consensus Estimate. However, this compares unfavorably with earnings of 26 cents per share in the year-ago quarter. The year-over-year decrease in earnings was due primarily to a 19.2% decline in net revenue to $1.0 billion. Net revenue decreased primarily as a result of lower net interest revenue (down 34.2%) and asset management & administration fees (down 24.3%), partly offset by noncredit portion of loss recognized in other comprehensive income of $41 million. Falling interest rates and lower equity market valuations significantly impacted the revenue during the quarter. However, these have been partially offset by cost containment measures. Client trading activity slowed modestly from the prior-year levels, leading to a 4.4% drop in trading revenue to $241 million. Net income for the quarter decreased 2.4% ...

SCHW Schwab Reports Monthly Activity Highlights August 14, 2009

stock-pr (August 14th, 2009) Writes:

The Charles Schwab Corporation released its Monthly Market Activity Report today. Company highlights for the month of July 2009 include:

* Net new assets brought to the company by new and existing clients in July 2009 totaled $5.6 billion. * Total client assets were $1.286 trillion as of month-end July, down 8% from July 2008 and up 5% from June 2009. * Client daily average trades were 291.1 thousand in July 2009, down 14% from July 2008 and down

The SMART report can be viewed with its accompanying 12-month data at http://www.aboutschwab.com/investor/financials/financial_reports.html

About Charles Schwab

The Charles Schwab Corporation (Nasdaq:SCHW - News) is a leading provider of financial services, with more than 300 offices and 7.6 million client brokerage accounts, 1.5 million corporate retirement plan participants, 619,000 banking accounts, and $1.3 trillion in client assets. Through its operating subsidiaries, the company provides a full range of securities brokerage, banking, money management and financial

...

New Schwab Fund: “Pure Growth” – Analyst Blog

Zacks Market Commentaries (July 13th, 2009) Writes:
Charles Schwab introduces Laudus Growth Investors U.S. Large Cap Growth Fund On July 13, 2009, Charles Schwab Investment Management, Inc. the asset management subsidiary of Charles Schwab Corporation (SCHW) announced the launch of the Laudus Growth Investors U.S. Large Cap Growth Fund. The newly-launched fund is a successor to the UBS U.S. Large Cap Growth Fund and the latest addition to its array of Laudus Funds. The Laudus Growth Investors U.S. Large Cap Growth Fund will resort to a "pure growth" strategy, with an objective to yield consistent performance through the application of fundamental growth discipline backed by extensive research and invaluable investment industry experience of the portfolio management team at Growth Investors. The fund will identify and invest in companies believed to have potential for sustainable above-average sales and profit growth. The Laudus Growth Investors U.S. Large Cap Growth Fund will retain the performance ...

Zacks Analyst Blog Highlights: AstraZeneca, Darden Restaurants, Inc., Charles Schwab Corporation, Stein Mart and Shire – Press Releases

Zacks Market Commentaries (June 29th, 2009) Writes:
For Immediate Release

Chicago, IL - June 29, 2009 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: AstraZeneca (AZN), Darden Restaurants, Inc. (DRI), Charles Schwab Corporation (SCHW), Stein Mart (SMRT) and Shire (SHPGY).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Friday's Analyst Blog:

AstraZeneca's Pipeline Must Deliver

We currently rate shares of AstraZeneca (AZN) a Hold with a $47 price target. The company is facing a number of challenges as it enters 2009, most notably generic competition to Toprol-XL, Nexium, Casodex and Pulmicort.

The just-announced increase

...

Chas. Schwab to Bolster Growth – Analyst Blog

Zacks Market Commentaries (June 26th, 2009) Writes:
On June 25, 2009, Charles Schwab Corporation (SCHW), the largest independent investment advisor in the U.S., disclosed a series of new initiatives that will help the company grow significantly by managing costs and improving their efficiency.SCHW's client-advisor relationship has been facing significant dilemmas due to the ongoing troubled market condition. And, as there is a need for greater efficiency in their businesses, the current clients require more involvement from their advisors.To make the best of this situation, SCHW announced a series of steps to support advisors in the current environment. This will translate into significant benefits since SCHW is the leading provider of custodial, operational and trading support for more than 6,000 independent fee-based investment advisory firms.The steps announced by SCHW are as follows:1) Beginning in July 2009, SCHW will waive commissions on electronic equity trades and reimburse ...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.